An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures  by Ting, Sherwin et al.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
ScienceDirect
www.e l sev i e r . com / l oca te / s c r
Stem Cell Research (2014) 13, 202–213An intermittent rocking platform for
integrated expansion and differentiation
of human pluripotent stem cells to
cardiomyocytes in suspended
microcarrier cultures
Sherwin Ting, Allen Chen, Shaul Reuveny, Steve Oh⁎Bioprocessing Technology Institute, A*STAR (Agency for Science, Technology and Research), Singapore 138668, SingaporeReceived 28 April 2014; received in revised form 13 June 2014; accepted 17 June 2014
Available online 27 June 2014Abstract The development of novel platforms for large scale production of human embryonic stem cells (hESC) derived
cardiomyocytes (CM) becomes more crucial as the demand for CMs in preclinical trials, high throughput cardio toxicity assays
and future regenerative therapeutics rises. To this end, we have designed a microcarrier (MC) suspension agitated platform
that integrates pluripotent hESC expansion followed by CM differentiation in a continuous, homogenous process.
Hydrodynamic shear stresses applied during the hESC expansion and CM differentiation steps drastically reduced the capability
of the cells to differentiate into CMs. Applying vigorous stirring during pluripotent hESC expansion on Cytodex 1 MC in spinner
cultures resulted in low CM yields in the following differentiation step (cardiac troponin-T (cTnT): 22.83 ± 2.56%; myosin heavy
chain (MHC): 19.30 ± 5.31%). Whereas the lower shear experienced in side to side rocker (wave type) platform resulted in
higher CM yields (cTNT: 47.50 ± 7.35%; MHC: 42.85 ± 2.64%). The efficiency of CM differentiation is also affected by the
hydrodynamic shear stress applied during the first 3 days of the differentiation stage. Even low shear applied continuously by
side to side rocker agitation resulted in very low CM differentiation efficiency (cTnT b 5%; MHC b 2%). Simply by applying
intermittent agitation during these 3 days followed by continuous agitation for the subsequent 9 days, CM differentiation
efficiency can be substantially increased (cTNT: 65.73 ± 10.73%; MHC: 59.73 ± 9.17%). These yields are 38.3% and 39.3% higher
(for cTnT and MHC respectively) than static culture control.
During the hESC expansion phase, cells grew on continuously agitated rocker platform as pluripotent cell/MC aggregates
(166 ± 88 × 105 μm2) achieving a cell concentration of 3.74 ± 0.55 × 106 cells/mL (18.89 ± 2.82 fold expansion) in 7 days.
These aggregates were further differentiated into CMs using a WNT modulation differentiation protocol for the subsequent
12 days on a rocking platform with an intermittent agitation regime during the first 3 days. Collectively, the integrated MC
rocker platform produced 190.5 ± 58.8 × 106 CMs per run (31.75 ± 9.74 CM/hESC seeded). The robustness of the system wasAbbreviations: cTnT, cardiac troponin-T; CM, cardiomyocyte; EB, embryoid body; hESC, human embryonic stem cells; hiPSC, HUMAN
induced pluripotent stem cells; MC, microcarrier; MHC, MYOSIN heavy chain
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203demonstrated by using 2 cells lines, hESC (HES-3) and human induced pluripotent stem cell (hiPSC) IMR-90. The CM/MC
aggregates formed extensive sarcomeres that exhibited cross-striations confirming cardiac ontogeny. Functionality of the CMs
was demonstrated by monitoring the effect of inotropic drug, Isoproterenol on beating frequency.
In conclusion, we have developed a simple robust and scalable platform that integrates both hESC expansion and CM
differentiation in one unit process which is capable of meeting the need for large amounts of CMs.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Cardiovascular disease is one of the major causes of death
in the United States, accounting for 31.9% of all deaths in
2010 (Go et al., 2014). The discovery that functional
cardiomyocytes (CM) can be obtained from human
embryonic stem cells (hESC) or human induced pluripo-
tent stem cells (hiPSC) (Itskovitz-Eldor et al., 2000; Zwi
et al., 2009), led to the increase in research directed
toward the utilization of these CMs as a potential source
for treating heart diseases by cell therapy (Burridge
et al., 2012). As such, substantial effort has been made
to improve CM differentiation efficiencies (Burridge et
al., 2011; Lian et al., 2012) by developing multiple
differentiation protocols with some capable of producing
more than 90% pure populations of CMs (Burridge et al.,
2012; Chen et al., 2014; Xu, 2012) in lab-scale 2D
platforms. However, due to the large quantities of CMs
needed for cell therapy, development of methodologies
for 3D suspended scalable production platforms still
remain a major challenge (Burridge et al., 2012; Chen
et al., 2014).
Due to the limited proliferative capability of CMs, large
scale production of CMs is based on the expansion of
pluripotent hESC followed by a CM differentiation step
(Chen et al., 2014). Scaling up of hESC expansion in
monolayer (MNL) culture platform is problematic mainly
due to surface area limitation. One of the approaches
to overcome this hurdle is the use of suspended 3D
microcarriers (MC) which can provide large surface area
per culture volume (Oh et al., 2009; Chen et al., 2011). Oh
et al. demonstrated that hESC can be expanded to densities
of 3.5 × 106 cells/mL (18 fold expansion) in MC spinner flask
culture while retaining hESC pluripotency, ability to
differentiate into the 3 germ layers, and normal karyotypes
(Oh et al., 2009). In comparison, parallel hESC expansion on
MNL platforms achieved densities of 0.8 × 106 cells/mL
(4 fold expansion) (Oh et al., 2009).
Induction of CM differentiation can be achieved by using
small molecules (Lian et al., 2013; Graichen et al., 2008;
Minami et al., 2012) or growth factors (Sa and McCloskey,
2012; Kattman et al., 2011). High differentiation efficiencies
can be achieved by both methods, however, the small
molecule approach provides a distinct advantage in terms of
cost and reproducibility and thus has the ability to be
amenable to GMP standards (Kirouac and Zandstra, 2008).
One example of a highly efficient small molecule CM
differentiation protocol is reported by Lian et al. (2012,
2013). In this protocol, CM differentiation is initiated by
WNT pathway activation at day 0 using CHIR99021 (CHIR) or
6-bromoindirubin-3′-oxime (BIO) and is followed by itsrepression at day 3 using inhibitors, IWP-2 or IWP-4.
Differentiation efficiencies of up to 98% cardiac troponin-T
positive cells were reported for MNL cultures.
CM differentiation in 2D MNL cultures can achieve
high differentiation efficiency but is limited in scalability
(Rowley et al., 2012). In comparison, protocols using 3D
suspended embryoid body (EB) cultures achieve lower
differentiation efficiencies (Chen et al., 2014) but have
the ability to be scaled up volumetrically (Niebruegge et al.,
2008). Generating EB structures is problematic though,
since it requires extensive cell handling as pluripotent cells
need to be dissociated and re-aggregated to the appropriate
size, in order to create efficient EBs for further differenti-
ation. This causes difficulties in maintaining reproducibility
and cell viability, thus limiting its ability to be developed
into an efficient and robust bioprocess (Placzek et al.,
2009).
In the present study, we attempt to integrate MC
suspension based pluripotent hESC expansion followed by
CM differentiation using the WNTmodulation protocol (Lian
et al., 2012) as a continuous process in order to increase the
efficiency of CM differentiation. Hydrodynamic shear stress
applied during culture agitation was found to drastically
affect CM yields. Expansion of HES-3 in the vigorously
agitated MC spinner culture resulted in 38.1% reduction of
CM yield in the following differentiation step, as compared
to static control MC cultures. While hESC expanded in the
gentler rocker platform achieved an increase of 32.1% CM
yield. Moreover, agitation applied during the first 3 days of
the differentiation process was also observed to have an
inhibitory effect on CM generation. Thus, an efficient CM
production platform was developed in which pluripotent
cells were expanded in continuously agitated rocker
culture followed by differentiation during which intermit-
tent rocking was applied only on days 1–3 followed by
continuous agitation until day 12. This MC based platform
provides 18.89 ± 2.82 folds of cell expansion and CM
differentiation efficiencies of 31.75 ± 9.74 CM/hESC hav-
ing 65.73 ± 10.73% and 59.73 ± 9.17% expression levels for
cTnT and MHC respectively. In total, this platform was
capable of producing 190.5 ± 58.8 × 106 CMs per run. The
robustness of the integrated MC rocker platform was
further demonstrated with an additional human induced
pluripotent stem cell (hiPSC) line, achieving 19.56 ± 0.44
CM/hiPSC. The CMs obtained from this process were
examined for structural and functional properties through
immunohistology and exposure to inotropic substance,
Isoproterenol, respectively. The new method offers a
simple means for the scalable production of CMs in large
quantities through the integrated bioprocess of cell
propagation and differentiation.
204 S. Ting et al.Materials & methods
Expansion and maintenance of hESC and hiPSC in ML
cultures
hESC (HES-3) ([46 X, X]; ES Cell International) and human
induced pluripotent stem cell (hiPSC) (IMR-90) ([46 X, X];
provided by James Thomson (Yu et al., 2007)) with normal
karyotypes were cultured in mTeSR™1 (Stemcell Technologies)
medium on tissue culture plates coated with Matrigel™ (BD) at
37 °C in 5% CO2 incubator, following a previously described
protocol (Choo et al., 2006).Expansion of hESC and hiPSC in MC cultures
Fig. 1A presents the different MC cultures expansion process
used in this work: (i) MC static culture, (ii) MC rocker culture,
and (iii) MC spinner culture. All cultures used Cytodex 1MCs (GE
healthcare) at a concentration of 1 mg dry weight/mL coated
with Matrigel™ (BD). Protocols for preparation, sterilizationFigure 1 Schematic diagram demonstrating maintenance, expans
(A), and steps of the WNT based CM differentiation protocol (B). Plat
Platforms for hESC expansion phase: (i) MC static culture, (ii) MC
differentiation phase: (I) MC static culture and (II) MC rocker culture
Effects on CM differentiation efficiency” is indicated by “—” dotted l
of agitation on CM differentiation efficiency” is indicated by “—” doand coating of MCs are previously described in Chen et al.
(2011). The cultures were maintained for 7 days in mTeSR™1
(Stemcell Technologies) medium, at 37 °C in 5% CO2 incubator
with 80% of the medium refreshed daily.
For initiation of MC static cultures, cells from MNL cultures
were enzymatically detached (Dispase; Invitrogen) into small
clumps (100 μm) and seeded at 2 × 105 cells/mL into ultra-low
attachment six-well plates (Corning) containing 5 mg MCs in
5 mL of mTeSR™1 per well. After 7 days of propagation, cell
passage was done by mechanically dissociation of the cell/MC
aggregates into small clumps (1–3 Cytodex 1 MCs per clump),
which were transferred at 2 × 105 cells/mL into new six-well
plates containing 5 mg MCs in 5 mL of medium per well. These
static MC cultures were maintained for up to 10 passages
without losing their pluripotency (Fig. 1A) (Oh et al., 2009).
MC spinner flask cultures
MC spinner flask cultures were operated in a procedure similar
to the one previously described by Chen et al. (2011). Briefly,
cells obtained from MC static cultures were seeded at cellion and CM differentiation of hESC in several culture platforms
forms for maintenance: monolayer culture and MC static culture.
rocker culture, and (iii) MC spinner culture. Platforms for CM
. Experiment procedure for “hESC MC culture expansion phase:
ine. Experiment procedure for “CM differentiation phase: effects
tted line.
205concentration of 4 × 105 cells/mL into 100 mL spinner flasks
(BellCo) containing 25 mL medium and 50 mg MCs. Spinner
cultures were maintained static for one day. On the second
day, 25 mL ofmTeSR™1 was added and stirringwas initiated at
25 rpm. This is the minimal agitation speed that ensures even
suspension of aggregates.
MC rocker cultures
In MC rocker cultures, cells obtained from MC static cultures
were seeded at concentration of 4 × 105 cells/mL into ultra-
low attachment (ULA) T-25 flasks (Corning) (containing 15 mL
medium and 30 mg MCs) which were placed on laboratory
rocker (Thermo Scientific). After one day of static conditions,
15 mL medium was added and the cultures were agitated at
rocking rate of 30 oscillations/min and at a tilt angle of 12°.
Rocking speed and tilt angle was pre-determined to ensure
even suspension of aggregates.
Differentiation of hESC and hiPSC on MCs
Pluripotent cell/MC aggregates obtained from MC static, MC
spinner and MC rocker cultures were differentiated to CMs in
(I) static six-well ULA plate (MC static culture) and (II) ULA
T-25 flask on laboratory rocker (MC rocker culture).
Aggregates were washed (×3) by refreshing 80% of the
original medium volume with RPMI 1640 medium supple-
mented with B27-insulin (Invitrogen). Aggregate suspensions
were then diluted and seeded at a concentration of
1 × 106 cells/mL into three ULA T-25 flask or six-well ULA
plates with a total medium volume of 30–33 mL/flask or
5 mL/well respectively. Differentiation was done at 37 °C
with 5% CO2 according to a protocol previously described by
Lian et al. (2013) and is summarized in Fig. 1B. Briefly,
CHIR99021 (CHIR) in RPMI 1640 supplemented with
B27-insulin (Invitrogen) was added at concentration of
18 μM for the first 24 h and then removed via medium
change (day 0 to day 1). On day 3 of differentiation, cells
were treated to 5 μM IWP-2 (Stemgent) in RPMI 1640
supplemented with B27-insulin. IWP-2 was removed via
medium change on day 5 and cells were maintained in RPMI
1640 supplemented with B27-insulin thereafter. On day 12,
cultures were harvested for analysis. In some rocking
cultures, intermittent agitation (6 min on 66 min off) was
introduced in the first 1, 2 and 3 days of differentiation to
evaluate shear stress on cardiogenesis. Results were quan-
tified by comparing the yields of CM/hESC seeded which
refers to the amount of CMs generated per hESC seeded at
the beginning of the hESC expansion or differentiation
phase.
The integrated process that includes hESC propagation,
the transition from hESC expansion to CM differentiation and
harvesting the CMs at day 12 of differentiation is referred to
as a “production run”.
Separation of microcarriers from cardiomyocyte
cultures
CM/MC aggregates, harvested on day 12 of differentiation,
were enzymatically dissociated into a single cell/MC sus-
pension using Tryple™ (1x; 15–20 min) (Invitrogen). Thesingle cell/MC suspension was subsequently passed through a
40 μm cell strainer (Becton Dickinson) to separate the cells
from the MCs.
Western blotting
Cells were lysed with lysis buffer (Cell Signaling Technology)
containing 1 mM phenylmethylsulfonyl fluoride (PMSF)
(Sigma), 1× protease inhibitor cocktail (Nacalai Tesque) and
1× phosphatase inhibitor cocktail (Roche). Proteins (50 μg/
well) were separated on 4–12% gradient Bis–Tris NuPage gels
(Life Technologies) and blotted on methanol-activated PVDF
membrane (Bio-rad). Thereafter, blocked membranes were
incubated with a specific goat anti-human SMAD7 antibody
(1:500; Genetex) overnight at 4 °C in the same blocking
buffer. Membranes were washed with 0.1% Tween-20
(Bio-rad) in Tris-buffered saline (1st BASE), and incubated
with anti-rabbit-HRP conjugate (1:10,000; Dako) for 90 min at
room temperature. Immunocomplexes were visualized with an
Immobilon Western Chemiluminescent HRP substrate
(Millipore) on a chemiluminescence detection imaging instru-
ment (LAS500; GE Healthcare).
qRT-PCR
Total RNA was isolated from the cells (N5 × 106) using both
Trizol (Invitrogen) and RNeasy Mini Kit (Qiagen) following the
supplier's protocol. Reverse transcription was carried out with
1 μg total RNA using Maxima First Strand cDNA synthesis kit
(Fermentas). Real-time PCR was performed by applying a
standard two-step amplification protocol on an ABI 7500
system (Applied Biosystem) to detect mRNA expression.
Relative expression values were obtained by normalizing Cτ
values of the tested genes to the Cτ values of the house
keeping gene GAPDH using the ΔΔCτ method. Primer
sequences are provided in Supplementary Table 1.
Immunohistology
CM cell aggregates were harvested on day 12 of differentiation,
washed with phosphate-buffered saline (PBS) with Ca2+/Mg2+,
and fixed with fixing reagent A (Invitrogen). Cryo-sectioned
slides were washed twice with PBS, permeabilized and blocked
by 0.1% Triton X-100 and 10% goat serum respectively. The
following antibodies were used: anti-MYL-2A (MLC-2A; Synaptic
Systems), anti-SA (Sigma), and anti-troponin-T (Thermo Scien-
tific). Nuclear staining was done using Slow Fade Glow with
DAPI (4′6-diamidino-2-phenylindole) (Invitrogen). The fluores-
cence was observed using a Nikon TI–E fluorescence micro-
scope coupled with Nikon imaging software, NIS elements.
Flow cytometry
Aggregates were dissociated into single cells with Tryple™ (1x)
(Invitrogen) and the cell/MC suspension was filtered through a
40 μm cell strainer (Becton Dickinson) to remove the MCs.
Subsequently, cells were fixed and permeabilized (Invitrogen)
according to manufacturer's directions and incubated with
primary antibodies, anti-myosin heavy chain (anti-MHC; MF20,
1:200; Developmental Studies Hybridoma Bank) and anti-
206 S. Ting et al.troponin-T (anti-cTnT; 1:200; Thermo Scientific) for CM
differentiation efficiency assessment and OCT 4 (1:100; R&D
Systems), mAB84 (1:20) (Choo et al., 2008) and SSEA4 (1:100;
BioLegend) for hESC pluripotency assessment. Alexa Fluor
647® goat anti-mouse (Invitrogen) was used as the secondary
antibody. All incubations were conducted at room tempera-
ture for 30 min. Fluorescent measurements were done using
flow cytometer (GUAVA, Millipore).
Metabolite analysis
Metabolite analysis (glucose, lactate, ammonium and gluta-
mine) were determined by Bioprofile 100 plus (NOVA). Methods
for calculating specific metabolite consumption and waste
product production rates are described previously by Chen et al.
(2010).
Toxicology assay
Contracting CM aggregates were transferred into ultra-low
attachment 96-well plates (Corning). Cardiac inotropic
substance, Isoproterenole (Sigma-Aldrich), was added at 1 μM
concentration. Videos were recorded before and after addition
of cardiac toxic drugs and were analyzed for beating frequency
changes using an imaging platform (TVAMS) previously
described by Ting et al. (2014).
Cell count
Aggregates cultures were swirled to form a uniform mixture
then sampled and lysed for total and viable cell count using a
nuclei count method with DAPI using NucleoCounter NC-3000
(Chemometec) according to the manufacturer's instructions.
Aggregate size measurement
Aggregate sizes were evaluated by measuring the two-
dimensional area of the microscopic images of the aggregates
(n N 50) using Nikon TI–E phase contrast microscope coupled
with Nikon imaging software, NIS elements.
Statistics
For comparison between two data sets, significance was
calculated by Bonferroni corrected Student's t-test. For
comparison between multiple data sets, significance was
calculated by Bonferroni corrected one-way ANOVA test. Error
bars indicated on figures represent +/− standard deviations of
at least 3 repetitions.
Results
hESC MC culture expansion phase: Pluripotent cell
growth in spinner or rocking systems and the effects
on subsequent CM differentiation efficiency
Large quantities of pluripotent hESC can be obtained in
scalable agitated MC culture (Wang et al., 2005). However,
the shear stress introduced by agitation is known to affectcell viability, cell pluripotency and most importantly, the
ability of cells to differentiate (Leung et al., 2011; Earls et
al., 2013). For this reason, MC cultures with three levels of
shear rates: (i) MC static culture, and (ii) MC Rocker culture
(approximately 0.1 dyn/cm2 as measured in previous study
(Oncul et al., 2010)) (iii) MC spinner culture (approximately
1.1 to 2.4 dyn/cm2 as measured in previous studies (Santos
et al., 2011; Sucosky et al., 2004)) were assessed for hESC
expansion, hESC pluripotency and subsequent CM differen-
tiation efficiency. The flow of these experiments is
presented in Fig. 1A, dotted line “—”. Both agitated cultures
(MC spinner culture and MC rocker culture) demonstrated
shorter doubling times and higher cell yields than the
MC static culture control. Doubling times of 34 ± 4 and
37 ± 7 h for MC spinner culture and MC rocker culture
respectively as compared to 102 ± 7 h for MC static culture
and cell yields of 2.95 ± 0.20 × 106 and 3.74 ±0.55 ×106 cells/
mL for MC spinner culture and MC rocker respectively as
compared to 1.44 ± 0.17 × 106 cells/mL MC static culture
(Fig. 2A). Cell viability was not affected (above 85%) in all
3 systems (MC static, MC rocker and MC spinner).
The metabolic activity of the cells was similar in all
systems (qGlc =0.36 ± 0.03 mmol/109 cells/h; qLac = 0.74 ±
0.07 mmol/109 cells/h; qGln = 0.032 ± 0.002 mmol/109 cells/h;
qAmm = 0.025 ± 0.002mmol/109 cells/h; Ylac/Glc = 2.06 ± 0.06;
YAmm/Gln = 0.79 ± 0.12). However, the mode of cell propaga-
tion had a significant effect on the shape and size of the cell-MC
aggregates. In static cultures, very large (N180 × 105 μm2)
non-uniform amorphous aggregates were seen (Fig. 2C). In the
agitated cultures, more defined uniform sized spherical shapes
were generated (Fig. 2C), with the gentler agitated MC rocker
culture system resulting in larger sized aggregates (166 ±
88 × 105 μm2) as compared to the more vigorous MC spinner
cultures (85 ± 42 × 105 μm2) (Figs. 2B and C). Variance in
aggregate sizes was also large in MC rocker cultures in com-
parison to MC spinner cultures. The different levels of shear did
not affect pluripotency with expression levels of OCT4, mAB84
and SSEA4 above 90% in all the cultures at day 7 of growth.
The aggregates from the 3 systems were transferred to
six-well plates, differentiated for 12 days in static conditions
using the WNT protocol (Fig. 1B), and subsequently evaluated
for cell yields and differentiation efficiency. Cell expansion
during the differentiation process was similar in all system
(cell fold expansion between 1.28 and 1.57 and cell viability
above 90%). However, higher expression levels of cTnT
(36.95 ± 2.07% and 47.50 ± 7.35%) and MHC (31.58 ± 9.64%
42.85 ± 2.64%) was obtained in cultures which were expanded
in static and rocking systems respectively as compared to
those expanded in the MC spinner cultures (22.83 ± 2.56%
(cTnT) and 19.30 ± 5.31% (MHC)) (Fig. 2D). Collectively, the
results confirm that pluripotent cell expansion in the MC rocker
culture platform is themethod of choice for further exploration,
since high cell yields were obtained. More importantly, the
following CM differentiation efficiency was not affected by the
agitation applied during the expansion phase.hESC CM differentiation phase: effects of agitation
on CM differentiation efficiency
Preliminary experiments (not shown) demonstrated that
cell/MC aggregates obtained from static or agitated cultures
Figure 2 Cell yields, pluripotency and CM differentiation potential of HES-3 hESC expanded in suspended MC cultures in agitated
rocker and spinner platform. HES-3 were expanded in three different platforms: MC static, MC spinner, and MC rocker for 7 days and
evaluated for (A) cell growth kinetics and viability, (B & C) aggregate size and shape (n = 50, *p b 0.001, Bonferroni corrected), and
(D) effects on efficiency of the following CM differentiation step in static MC cultures (n = 3, *p b 0.001, Bonferroni corrected).
207treated by the WNT differentiation protocol regime (Fig. 1B)
for 12 days under continuous agitation (rocker) does not
exhibit significant CM differentiation (cTnT expression
below 5% as compared to 47.50 ± 7.35% in static cultures)
indicating that the shear stress during agitation inhibits CM
differentiation process. We therefore examined whether
applying intermittent agitation (6 min on/66 min off) for 1,
2 or 3 days followed by continuous agitation might improve
cardiogenesis in comparison to continuous agitation from
day 0.
HES-3 cells expanded on the MC rocker platform for 7 days
were further differentiated for 12 days (T-25 flask) on therocker platform (The flow of the experiment is demonstrated
in Fig. 1A, dotted line “—”). Intermittent agitation was
applied for 1, 2 or 3 days followed by continuous agitation.
Static and continuous agitated cultures were used as positive
and negative controls respectively. As expected, continuous
agitation for 12 days utterly inhibits the CM differentiation
process (cTnT b 5%; MHC b 2%); while in static MC cultures,
high expression levels of cTnT (47.50 ± 7.35%) and MHC
(42.85 ± 2.64%) were achieved (Fig. 3A). It was found that
maintenance of intermittent agitation for the first 3 days is
essential for efficient CM differentiation. High differentiation
efficiency (65.73 ± 10.73 and 59.73 ± 9.17% expression of
Figure 3 Effects of agitation during the first 3 days of differentiation on CM yields. Pluripotent HES-3 cell/MC aggregates obtained
from rocker cultures were differentiated in intermittently agitated MC rocker for the first 1, 2 or 3 days followed by continuous
agitation for the following 11, 10, and 9 days respectively. Continuous agitated MC rocker cultures and static MC cultures were
operated in parallel as controls. (A) Cell yield and expression levels cardiac troponin-T (cTnT) and myosin heavy chain (MHC) (n = 3,
*p b 0.001, Bonferroni corrected) and the (B) shape of cell/MC aggregates were recorded after 12 days of differentiation.
208 S. Ting et al.cTnT and MHC markers respectively) was achieved as
compared to 5.43 ± 3.82% cTnT and 8.08 ± 4.45% MHC for
cultures in which intermittent agitation was maintained for
only 1 or 2 days (Fig. 3A). Intermittent agitation for just 1 or
2 days did not improve cardiogenesis.
Cell expansion during the differentiation process was
higher in all agitated cultures as compared to static conditions
(2.31 ± 0.34 × 106 vs. 1.54 ± 0.12 × 106 cells/mL) again pro-
bably due to diffusional limitations in static cultures (Fig. 3A).
Aggregates generated in the intermittent agitated (3 days)
MC rocker culture system were larger in size as compared
to aggregates generated in continuous agitated MC rocker
culture system (148.94 ± 52.92 × 105 μm2 vs. 78.09 ± 37.42 ×
105 μm2 respectively) (Fig. 3B).
In summary, the results indicate that the MC rocker
culture platform that incorporates hESC expansion follow-
ed by a differentiation step with intermittent agitation
regime for only the first 3 days of differentiation, can be
used as an efficient, one unit, integrated system for CMs
production.Characterization of the integrated platform: repro-
ducibility of cell growth, metabolism of glucose and
glutamine, robustness, and gene expression during
differentiation
Multiple production runs, which includes both the hESC
expansion and CM differentiation steps, was conducted on the
MC rocker platform to further analyze for reproducibility of cell
growth, CM yields, metabolism of glucose and glutamine,
universality, and gene expression during differentiation.
During hESC expansion, cell yields of 3.74 ± 0.55 ×
106 cells/mL with 96.10 ± 3.44% viability were achieved
(n = 4) (Table 1A). At the end of the expansion phase, 166 ±
88 × 105 μm2 cell/MC aggregates were obtained and plu-
ripotent markers were above 90%.
During the first day of differentiation (after addition of
CHIR99021), cell viability dropped to 71.66% and conse-
quently during the next day, a drop in cell density was
observed (from 1 × 106 cells/mL to 4.55 × 105 cells/mL)
(Fig. 4A). The drop in cell viability was probably due to the
Table 1 hESC (HES-3) and hiPSC (IMR-90) expansion and CM differentiation in rocker plate platform.
(A) hESC expansion phase (day 7 of growth)
Cell line Cell expansion Pluripotent markers
Viable cell count
(cells/mL)
Viability (%) Cell expansion
fold
OCT4 (%) mAB84 (%) SSEA4 (%)
HES-3 ⁎ 3.74 ± 0.54 × 106 96.10 ± 3.44 18.89 ± 2.82 95.95 ± 3.46 97.03 ± 0.92 98.6 ± 0.85
hiPS (IMR-90) ⁎ 3.50 ± 0.42 × 106 98.40 ± 1.33 17.52 ± 2.09 94.25 ± 1.06 93.09 ± 2.62 93.20 ± 4.52
(B) Cardiomyocyte differentiation phase (day 12 of differentiation)
Cell line Cell expansion CM markers Production
Viable cell count
(cells/mL)
Cell expansion
fold
cTnT (%) MHC (%) CM/mL CM/seeded
hESC
HES-3 ⁎⁎ 2.45 ± 0.12 × 106 2.44 ± 0.15 65.73 ± 10.73 59.73 ± 9.17 1.61 ± 0.36 × 106 1.62 ± 0.36
hiPS (IMR-90) ⁎⁎ 2.31 ± 0.33 × 106 2.31 ± 0.33 46.65 ± 5.73 46.55 ± 3.75 1.20 ± 0.07 × 106 1.20 ± 0.07
(C) Integrated platform for hESC expansion and cardiomyocyte differentiation (7 days of expansion followed by 12 days of differentiation)
Cell line Cell expansion Production of cTnT positive CMs
(fold) CM/seeded hESC Total CM per production run
HES-3 ⁎ 47.91 ± 8.94 31.75 ± 9.74 190.5 ± 58.8 × 106
hiPS (IMR-90) ⁎ 42.10 ± 2.70 19.56 ± 0.44 117.4 ± 2.7 × 106
⁎ Cell seeded at 2 × 105 cells/mL.
⁎⁎ Cell seeded at 1 × 106 cells/mL.
209abrupt change from hESC culture medium (mTeSR™1)
to differentiation medium which lacks insulin (as insulin
inhibits differentiation (Freund et al., 2008)). However,
subsequent cell growth between days 3–12 resulted in
overall 2.45 ± 0.12 fold expansion with cell density of
2.45 ± 0.12 × 106 cells/mL achieved (n = 6;99.56 ± 0.20%
viability). Expression levels of cTnT and MHC were 65.73 ±
10.73% and 59.73 ± 9.17% respectively (Table 1B).
The entire integrated process which took 19 days (7 days
hESC expansion and 12 days differentiation) resulted in
190.5 ± 58.8 × 106 CMs/production run and 31.75 ± 9.74
positive cTnT CMs per hESC seeded at the beginning of the
expansion phase (Table 1C).
During the differentiation phase, cells exhibit longer
doubling time (131.46 ± 33.6 h vs 37 ± 7 h) and lower meta-
bolic activity in comparison to the expansion phase. Specifi-
cally, glucose consumption (0.10 ± 0.01 mmol/109 cells/h)
and lactate production (0.10 ± 0.02 mmol/109 cells/h)
rates as well as specific glutamine consumption (0.06 ±
0.01 × 101 mmol/109 cells/h) and ammonium production
rates (0.04 ± 0.01 × 101 mmol/109 cells/h) were lower com-
pared to these metabolic parameters measured during the
expansion phase (0.38 ± 0.18; 0.77 ± 0.38; 0.31 ± 0.10 × 101;
0.27 ± 0.06 × 101 mmol/109 cells/h respectively). It is impor-
tant to note that glucose consumption is more aerobic during
the differentiation phase in comparison to the expansion
phase (YLac/Glc 0.96 ± 0.08 vs. 1.99 ± 0.02 respectively) while
glutamine metabolism is similar (YAmm/Gln = 0.81 ± 0.13).
During the first 3 days of CM differentiation, a down
regulation of pluripotent markers, OCT4 and Nanog were
observed (Fig. 4B). This was followed by an up regulation of
mesoderm marker, T-bra, and cardiac progenitor markers,
Nkx2.5 and ISL-1 during the next 3 days (Fig. 4B). During thelast 5 days of differentiation, up regulation of the CM marker,
MHC, was observed (Fig. 4B).
A process for the separation of CMs from the MCs was
also developed. The CM/MCs aggregates generated using
the integrated platform was separated using an enzymatic
dissociation process and a 40 μm cell strainer. Cell viability
and cell recovery for this cell separation process was 88.33 ±
0.02% and 90.56 ± 2.84% respectively.
The robustness of the integrated platformwas validated by
using an additional hiPSC cell line (IMR-90) (Table 1a–c).
Similar to HES-3 cultures, a total of 117.4 ± 2.7 × 106 cTnT
positive CMs per production run was produced with a purity of
46.65 ± 5.73% and a yield of 19.56 ± 0.44 cTnT positive CMs
per hiPSC seeded were obtained (Table 1C).Structural and functional characterization
CM structure of differentiated cell/MC aggregates was
evaluated by immunofluorescence (Fig. 5A). The aggregates
were stained positive for cardiac troponin-T (cTnT), myosin
light chain (MYL-2A) and sarcomeric α-actinin (SA), showing
organized sarcomere structures. Interestingly, there was a
higher expression of sarcomeric α-actinin (SA) and actin in
regions surrounding the MCs (Fig. 5B). The functionality of
the produced CMs was evaluated by monitoring the effect of
inotropic drug, Isoproterenol (1 μM), on beating frequency
using an imaging system previously developed by Ting et al.
(2014). The addition of the drug resulted in a 62% increase in
beating frequency (from 0.75 ± 0.11 to 1.29 ± 0.17 Hz)
(Fig. 5C). The long term stability of these beating cell/MC
aggregates was then demonstrated by maintaining the
aggregates in RPMI 1640 supplemented with B27-insulin
Figure 4 Cell growth and gene expression kinetics of HES-3 cell/
MC aggregates during CM differentiation on the MC rocker
platform. Pluripotent HES-3 cell/MC aggregates obtained from
rocker platform cultures were differentiated in MC rocker agitated
intermittently for 3 days followed by continuous agitation 9 days.
(A) Cell growth kinetics. (B) Pluripotent (Nanog, OCT4), mesoderm
(T-bra), cardiac progenitors (Nkx 2.5, ISL-1), and CMs (MHC) gene
expression kinetics (n = 4–6, *p b 0.001, Bonferroni corrected).
Figure 5 Histological and functional characterization of CMs
produced in the integrated cell expansion and differentiation
rocker platform. HES-3 differentiated CM aggregates were (A & B)
210 S. Ting et al.medium for 7 months, these aggregates displayed similar
beating frequencies as day 12 aggregates (0.75 ± 0.11 vs.
0.79 ± 0.14 Hz respectively) (Fig. 5C).immunostained for myosin light chain (MYL-2A), cardiac
troponin-T (cTnT), actin and sarcomeric α-actinin (SA) (nuclei
stained with DAPI), and cryo-sectioned and stained for H&E. Scale
bars = 40 μm. (C) Changes in average CM beating frequency due to
exposure to Isoproterenol (1 μM) and prolonged culture duration
conditions (7 months) (n = 10, *p b 0.001, Bonferroni corrected).Discussion
We present a suspended MC based integrated rocker platform
for hESC expansion and CM differentiation. It is capable ofproducing 190.5 ± 58.8 × 106 HES-3 or 117 × 106 hiPSC (IMR90)
derived CMs per production run at a purity of 65.73 ± 10.73%
and 46.65 ± 5.73% (cTnT) respectively, in a time frame of
19 days. This is equivalent to 31.75 ± 9.74 and 19.56 ± 0.44
211CM per seeded hESC/hiPSC for HES-3 and hiPSC (IMR90)
respectively.
Comparing the platform to static MC cultures, the
integrated platform demonstrates higher proliferative effi-
ciency (18.70 ± 2.82 and 2.45 ± 0.12 cell expansion fold
as compared to 7.20 ± 0.08 and 1.54 ± 0.12 during the
expansion and differentiation phases respectively). This differ-
ence in cell yields can probably be attributed to diffusional
limitation (especially oxygen) in static MC cultures (Kinney et
al., 2011). The CM production capabilities of this platform
(31.75 ± 9.74 CM/hESC seeded and 190.5 ± 58.8 × 106 CMs per
production run) far exceed yields reported in literature for 3D
MC and EB suspended cultures: Lecina et al. reported yields of
0.33 CM/hESC seeded in stirred spinner cultures using MCs
(Lecina et al., 2010); Niebruegge et al. (2009) reported yields of
39.8 × 106 CMs per production run using an EB differentiation
method in 125 mL stirred tank bioreactors; Ting et al. (2013)
reported yields of 0.59 CM/hESC using a protocol in which
pluripotent cells were expanded in MNL and differentiated as
EBs. Current MNL differentiation protocols using costly growth
factors are capable of producing 2 × 108 purified CMs per T225
flask (Burridge et al., 2012) which is three fold less in com-
parison to the production capabilities presented in this work
(1.90 ± 0.58 × 108 per T-75 flask). Moreover, MNL platforms are
not suitable for scale up due the limited surface area for
cell growth, limited capabilities for monitoring and control,
and requirement of extensive manual handling for multi-plate
processes.
The number of CMs needed to regenerate an infarcted
area after a heart attack is estimated to be from 1 × 109 to
2 × 109 (Jing et al., 2008). The integrated platform can be
scaled up using larger agitators (e.g. Wave bioreactors)
which are available at up to 500 L scale with full monitoring
control and automatic handling (GE Life Sciences) and is
capable of producing up to 1.33 × 1012 (estimated based on
current production yields). Moreover, volumetric productiv-
ity can be further optimized in these systems by increasing
MC concentration and optimization of medium feed strate-
gies as well as better monitoring of environmental conditions
(e.g. pH and dissolved oxygen control as well as control of
nutrients and waste products levels). Previous works have
reported that the CM differentiation process can be affected
by pH control, oxygen concentration (Niebruegge et al., 2009)
and lactate concentration (Tohyama et al., 2013). The small
molecule differentiation approach and the use of serum-free
media also make the platform more cost effective and
amenable to adaptation into GMP requirements.
During the hESC expansion phase, the observed difference
in aggregate size and variance between the rocker (166 ±
88 × 105 μm2) and spinner platforms (85 ± 42 × 105 μm2) can
be attributed to the difference in intensity of shear stress
applied in the systems (Oncul et al., 2010). Previous flow
characterization studies have shown that the minimum agita-
tion speed to evenly suspend the aggregates in the spinner
flask platform (25 rpm) generates at least 1.1 dyn/cm2
(Santos et al., 2011; Sucosky et al., 2004). In comparison,
flow characterization studies of rocking platforms for
aggregates suspension show that shear forces of 0.1 dyn/cm2
(Oncul et al., 2010) is required, a tenfold difference in
comparison to the spinner platform. The aggregates generat-
ed in the integrated platform are uniform in size (148.94 ±
52.92 × 105 μm2) and their generation does not requireextensive cell handling that is required for EB generation
(Kurosawa, 2007). Previous studies have shown that aggregate
sizes and uniformity have an effect on CM differentiation
efficiency with aggregate sizes between 200–800 μm (equiv-
alent to 12.5 × 105–200.9 × 105 μm2 assuming aggregates are
spherical) considered to be the optimal for cardiomyogenesis
(Niebruegge et al., 2009; Peerani et al., 2007). These values are
in agreement with the size of aggregates obtained in rocker
culture (148.94 ± 52.92 × 105 μm2).
One of the major challenges in scaling up of hESC
cultures is the effects of the mechanical stimulation
generated by the hydrodynamic shear forces which is an
inherent property of agitated cultures (Earls et al., 2013).
Previous studies done with mouse embryonic stem cells
have shown that fluid shear stress pre-conditioning pro-
motes endothelial morphogenesis of cells within embryoid
bodies (Nsiah et al., 2014). In addition, Metallo et al.
(Peerani et al., 2007) reported that shear stress induces
hESC elongation, up regulation of endothelial marker genes,
and parallel alignment of hESC (Earls et al., 2013; Metallo et
al., 2008). In this study, we found that the extent of the
shear forces applied during the hESC expansion phase has an
effect on CM differentiation. Specifically, cultures expand-
ed in spinner cultures, which has a high rate of shear stress
applied on the pluripotent cells during expansion, displayed
51.9% reduction in their capability to differentiate into CM
(cTnT: 22.83 ± 2.56% %) in comparison to lower shear stress
conditions in rocker cultures (cTnT: 47.50 ± 7.35%). How-
ever, a parallel study done in our group shows that by using
different in-house types of MCs (smaller in size, more rigid
and coated with purified extra cellular matrix molecules)
and different agitation regime (static periods on day 1 and
day 3 of differentiation), hESC cell propagated in spinner
flasks can be efficiently used for differentiation to CMs
(unpublished data). The reason for these effects is not clear
and requires further studies to elucidate how hESC responds
to mechanical stimuli and how this response affects CM
differentiation capabilities.
We have found that the shift from pluripotent expanding
cells to cells undergoing CM differentiation results in a
parallel shift in cell growth properties: increase in doubling
time (37 ± 7 h as compared to 131.46 ± 33.6 h) as well as, a
change in glucose metabolism from anaerobic to aerobic
(YLac/Glc = 1.99 ± 0.02 compared to 0.96 ± 0.08). Previous
studies have also demonstrated a shift in energy metabolic
phenotype of CMs as they undergo differentiation
(Lopaschuk and Jaswal, 2010; Chung et al., 2007). Specifi-
cally, as CMs become terminally differentiated, the major
source of energy changes from anaerobic glycolysis to
the more efficient aerobic mitochondrial fatty acid beta-
oxidation. Disrupting this respiratory change prevented
mitochondrial organization and compromised the energetic
infrastructure, causing deficient sarcomerogenesis and con-
tractile malfunction (Chung et al., 2007).
The three culture platforms (static, intermittent agitated
and continuously agitated) tested in this study present
different oxygen/nutrient diffusion rates, oxygen saturation
levels and shear force conditions. Specifically, the static
platform has low nutrient/oxygen diffusion rates, low oxy-
gen saturation levels and no shear force conditions. On the
other extreme, the continuously agitated platform has high
nutrient/oxygen diffusion rates, high oxygen saturation
212 S. Ting et al.levels and high shear force conditions. The intermittent
agitated platform follows a cyclic pattern of high and low
levels of nutrient/oxygen diffusion rates, oxygen saturation
levels and shear force conditions for the first 3 days and
subsequently follows the same conditions as the continuous-
ly agitated platform. The results in this study indicate a low
CM differentiation efficiency in continuously agitated cul-
tures (cTnT b 5%) and an improved efficiency when compar-
ing intermittent agitated vs. static cultures (65.73 ± 10.73%
vs 47.50 ± 7.35% cTnT positive cells). It is important to note
that the increase in oxygen saturation levels and CM
differentiation efficiencies in the intermittent agitated
platform compared to the static platform is contradictory
to previous works showing an increase in CM differentiation
efficiency in low oxygen tension environments (Burridge et
al., 2011; Niebruegge et al., 2009). As such, we suggest that
low shear forces play a more important role in an agitated
environment for CM differentiation in comparison to oxygen
saturation levels. Multiple protocols initiate CM differenti-
ation through activation of the TGF-β pathway directly by
addition of growth factors (Activin A and BMP4) (Burridge et
al., 2011; Kattman et al., 2011; Yang et al., 2008; Willems et
al., 2011) or indirectly with the addition of small molecules
(CHIR or BIO) (Lian et al., 2012). In addition, the temporal
exposure of these growth factors and small molecules has
been found to be extremely critical to differentiation
process (Kattman et al., 2011). Thus, we have tried to
correlate the inhibitory effect of agitation on CM differen-
tiation and the expression levels of SMAD7, an inhibitor of
the TGF-β pathway which was previously reported to be up
regulated during increased shear stress (Wang et al., 2008).
Interestingly, we found that SMAD7 is expressed at higher
levels in differentiating HES-3 cells maintained at continuous
agitation for the first 3 days as compared to control cultures
maintained by intermittent agitation (Supplementary Fig.
1A). Thus, it can be hypothesized that the inhibition of the
TGF-β pathway as a result of increased expression levels of
SMAD7 due to shear stress in agitated cultures, negatively
affects the CM differentiation process. However, the
elucidation of this mechanism will require further extensive
research that will be done in the future.
In conclusion, a 3D suspended MC rocker platform, similar
to a wave bioreactor, that integrates both hESC expansion
and CM differentiation has been developed and shown to be
capable of producing the highest quantities of CMs to date
(190.5 ± 58.8 × 106 cTnT positive CM/production run;
31.75 ± 9.74 cTnT positive CM/hESC). CMs expressed
cardiac-specific transcriptional factors, structural and func-
tional genes, and generation of cross-striated muscle
structure that recapitulate the process of cardiomyogenesis.
The platform requires minimal human-intervention, lab
space foot print and utilizes a cost effective and defined
approach for expansion and differentiation. This process is
amenable to GMP standards and can be adaptable to larger
production scales (controlled bioreactors) in response to the
current increasing demand for CMs.
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